Anerobe-Mediated Anticancer Gene Therapy

Brown, John Martin

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 5R01CA064697-06
• Application #: 6633117
• Study Section: Experimental Therapeutics Subcommittee 1 (ET)
• Program Officer: Wolpert, Mary K
• Project Start: 1996-09-01
• Project End: 2005-05-31
• Budget Start: 2003-06-01
• Budget End: 2004-05-31
• Support Year: 6
• Fiscal Year: 2003
• Total Cost: $294,673

Institution

• Name: Stanford University
• Department: Radiation-Diagnostic/Oncology
• Type: Schools of Medicine
• DUNS #: 009214214
• City: Stanford
• State: CA
• Country: United States
• Zip Code: 94305

Publications

Brown, J Martin (2002) Tumor microenvironment and the response to anticancer therapy. Cancer Biol Ther 1:453-8

Liu, S C; Minton, N P; Giaccia, A J et al. (2002) Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis. Gene Ther 9:291-6

Lemmon, M J; van Zijl, P; Fox, M E et al. (1997) Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment. Gene Ther 4:791-6